This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Pinduoduo Inc. Sponsored ADR (PDD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Pinduoduo Inc. Sponsored ADR (PDD) closed the most recent trading day at $93.81, moving -1.92% from the previous trading session.
Pinduoduo Inc. Sponsored ADR (PDD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Pinduoduo Inc. Sponsored ADR (PDD) closed at $97.98 in the latest trading session, marking a +0.85% move from the prior day.
Wall Street Analysts See Pinduoduo Inc. Sponsored ADR (PDD) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Pinduoduo Inc. Sponsored ADR (PDD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks.com featured highlights MercadoLibre, Axcelis Technologies, Shinhan Financial, Pinduoduo and Collegium Pharmaceutical
by Zacks Equity Research
MercadoLibre, Axcelis Technologies, Shinhan Financial, Pinduoduo and Collegium Pharmaceutical have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength Amid January Rally
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MELI, ACLS, SHG, PDD and COLL.
Is Trending Stock Pinduoduo Inc. Sponsored ADR (PDD) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Pinduoduo Inc. Sponsored ADR (PDD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks.com featured highlights include Lamb Weston, Pinduoduo and Catalyst Pharmaceuticals
by Zacks Equity Research
Lamb Weston, Pinduoduo and Catalyst Pharmaceuticals are part of the Zacks Screen of the Week article.
3 Top-Rated Profitable Stocks to Buy Using Net Income Ratio
by Tirthankar Chakraborty
Lamb Weston (LW), Pinduoduo (PDD), and Catalyst Pharmaceuticals (CPRX) have been selected as the top picks with a high net income ratio.
Pinduoduo Inc. Sponsored ADR (PDD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Pinduoduo Inc. Sponsored ADR (PDD) closed at $96.49, marking a +0.19% move from the previous day.
Is Pinduoduo (PDD) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Pinduoduo Inc. Sponsored ADR (PDD) and Performance Food Group (PFGC) have performed compared to their sector so far this year.